Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3563480)

Published in BMC Neurol on January 24, 2013

Authors

Stefanie Leistner1, Georg Michelson, Inga Laumeier, Michael Ahmadi, Maureen Smyth, Gabriele Nieweler, Wolfram Doehner, Jan Sobesky, Jochen B Fiebach, Peter Marx, Otto Busse, Friedrich Köhler, Holger Poppert, Martin L J Wimmer, Thomas Knoll, Paul Von Weitzel-Mudersbach, Heinrich J Audebert

Author Affiliations

1: Department of Neurology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. stefanie.leistner@charite.de

Associated clinical trials:

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack (PREVENTION) | NCT00931788

Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients (INSPiRE-TMS) | NCT01586702

Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication | NCT01684176

The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study (PREVENT) | NCT00253097

The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial (PREVENTS) | NCT01020851

Trial of a Secondary Stroke Prevention Program | NCT01071408

Articles cited by this

Actual causes of death in the United States, 2000. JAMA (2004) 44.38

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97

High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08

Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet (1993) 5.77

Short-term prognosis after emergency department diagnosis of TIA. JAMA (2000) 5.00

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J (2009) 1.84

Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke (2011) 1.64

Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res (2009) 1.63

Secondary preventive medication persistence and adherence 1 year after stroke. Neurology (2011) 1.62

Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med (2008) 1.32

Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis (2008) 0.95

An exploration of lifestyle beliefs and lifestyle behaviour following stroke: findings from a focus group study of patients and family members. BMC Fam Pract (2010) 0.89

Secondary prevention after minor stroke and TIA - usual care and development of a support program. PLoS One (2012) 0.86

Study protocol of the YOU CALL--WE CALL TRIAL: impact of a multimodal support intervention after a "mild" stroke. BMC Neurol (2010) 0.83

[Cardiovascular morbimortality reduction after an acute cardiovascular event through multifactorial and intensive cardiovascular risk factors management (MIRVAS project)]. Med Clin (Barc) (2007) 0.79

Articles by these authors

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44

2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation (2003) 3.89

Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke (2003) 3.53

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18

Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol (2013) 2.78

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74

Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology (2012) 2.60

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J (2012) 2.60

Physical activity and incident cognitive impairment in elderly persons: the INVADE study. Arch Intern Med (2010) 2.58

Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol (2007) 2.46

MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol (2006) 2.42

Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36

Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke (2002) 2.33

Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26

Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke (2004) 2.24

Standardized prehospital treatment of stroke. Dtsch Arztebl Int (2011) 2.21

Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke (2003) 2.15

The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol (2003) 2.12

Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. Stroke (2013) 2.11

Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol (2012) 2.11

Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro. Stroke (2005) 2.06

Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? Stroke (2009) 1.99

Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke (2002) 1.94

Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91

Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke (2003) 1.90

Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 1.90

Anemia and inflammation in COPD. Chest (2005) 1.83

Microembolic signals detected by transcranial Doppler sonography during carotid endarterectomy and correlation with serial diffusion-weighted imaging. Stroke (2004) 1.80

980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol (2007) 1.79

Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant (2009) 1.78

Shock wave technology and application: an update. Eur Urol (2011) 1.77

Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail (2009) 1.73

Acute stroke imaging research roadmap. Stroke (2008) 1.66

MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke (2007) 1.66

Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR). Stroke (2006) 1.64

Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology (2009) 1.59

Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke (2004) 1.58

Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement. Int J Cardiol (2006) 1.58

The quality of acute stroke care- an analysis of evidence-based indicators in 260 000 patients. Dtsch Arztebl Int (2014) 1.57

Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail (2003) 1.54

Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation. J Hypertens (2011) 1.53

Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion. Cerebrovasc Dis (2011) 1.53

3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol (2012) 1.52

Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51

Fully automated postprocessing carries a risk of substantial overestimation of perfusion deficits in acute stroke magnetic resonance imaging. Cerebrovasc Dis (2011) 1.50

Flexible ureterorenoscopy for the treatment of lower pole calyx stones: influence of different lithotripsy probes and stone extraction tools on scope deflection and irrigation flow. Eur Urol (2002) 1.50

5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 1.50

Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.48

Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48

Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47

Retracted Changes of radial diffusivity and fractional anisotropy in the optic nerve and optic radiation of glaucoma patients. ScientificWorldJournal (2012) 1.46

The small intestine: a critical linkage in pathophysiology of cardiac cachexia. Int J Cardiol (2010) 1.46

The low normothermia concept--maintaining a core body temperature between 36 and 37 degrees C in acute stroke unit patients. J Neurosurg Anesthesiol (2002) 1.44

New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens (2011) 1.44

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med (2005) 1.44

Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41

Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40

Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values. J Neurol (2010) 1.40

Haemoglobin and vascular function in the human retinal vascular bed. J Hypertens (2013) 1.39

Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke (2010) 1.39

PRESTO (a mammoth trial that could have been prevented), HPS and REMATCH. Int J Cardiol (2002) 1.38

Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience. World J Urol (2013) 1.37

The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle (2012) 1.35

Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke (2007) 1.34

Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension (2007) 1.33

Body weight after stroke: lessons from the obesity paradox. Stroke (2011) 1.31

Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke (2006) 1.31

A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke (2013) 1.29

120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol (2010) 1.29

Complications following acute ischemic stroke. Eur Neurol (2002) 1.25

Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke (2012) 1.24

Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res (2005) 1.22

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle (2011) 1.22

Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study. Ann Neurol (2010) 1.22

Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. J Clin Invest (2004) 1.22

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail (2011) 1.20

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18

Mobile computed tomography: prehospital diagnosis and treatment of stroke. Curr Opin Neurol (2015) 1.18

Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res (2006) 1.17

Three-dimensional laparoscopic imaging improves surgical performance on standardized ex-vivo laparoscopic tasks. J Endourol (2012) 1.17

Glaucoma risk index: automated glaucoma detection from color fundus images. Med Image Anal (2010) 1.17

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res (2012) 1.16

Gastrointestinal failure in intensive care: a retrospective clinical study in three different intensive care units in Germany and Estonia. BMC Gastroenterol (2006) 1.16

Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health (2011) 1.15

Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15

Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens (2009) 1.13

The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model. J Cereb Blood Flow Metab (2013) 1.12

Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke (2004) 1.12

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle (2011) 1.12

Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina (2004) 1.11

Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol (2004) 1.11